Documented clinical consequences of LAL Deficiency in patients around the world include hepatomegaly, splenomegaly, liver fibrosis, liver cirrhosis, liver transplant, premature atherosclerosis, premature cardiac events and death. The gene discussed is LIPA; the disease is hyperinsulinemic hypoglycemia, familial, 4.